ophthalmology

Fort Worth Ophthalmic Biotech Eyevance Exits to Japanese Firm for $225M

by | Sep 17, 2020
Eyevance Pharmaceuticals, which develops and commercializes ophthalmic products, has been purchased for $225 million by Santen, a Japanese leader in ophthalmology. Eyevance will join Santen's U.S. organization.
MORE
eyevensys
Fort Worth Biotech Eyevensys Completes $30M Series B Funding Round
by | Jan 8, 2020
The startup plans to use the funding to continue developing its technology and to position it as an innovator in ophthalmology. Eyevensys’ tech is a gene therapy platform to deliver ocular drugs via an electrotransfection system to the ciliary muscle of the eye.
MORE
Discovery: Work on Crystals Pays off for UTD Grad Student; UTSW Targets Rare Genetic Diseases in Children
by | May 10, 2019
You’ll also find out why the Association for Research in Vision and Ophthalmology has honored a professor at the UNT Health Science Center in Fort Worth in this roundup of research and development activity in North Texas.
MORE